Saralasin infusion in healthy volunteers reduced systolic blood pressure from 106.2 to 95.8 mm Hg during sodium restriction (P<0.05) and increased basal aldosterone secretion.
Does angiotensin II blockade by saralasin affect blood pressure and hormone levels in healthy volunteers?
Saralasin demonstrates angiotensin II-dependence of blood pressure during sodium restriction and appears to have an agonist effect on basal aldosterone secretion.
Absolute Event Rate: 95.8% vs 106.2%
p-value: p=< .05
To evaluate the role of angiotensin II in normal man, sar1-ala8-angiotensin II (saralasin), a specific competitive inhibitor of angiotensin II, was given by graded iv infusion (1–20 μg/kg/min over 1 h) to 6 healthy young volunteers. Significant ngiotensin II-dependence of blood pressure was found only after the combined stimulus of sodium restriction (10 mEq daily for 4 days) and ambulation. Systolic blood pressure fell during saralasin infusion from 106.2 ± 2.0 to 95.8 ± 2.9 mm (P < .05). At the same time, plasma renin activity rose strikingly from 3.3 ± 0.6 to 21.6 ± 8.5 ng/ml/h, and then fell to 9.3 ± 4.9 over the post-infusion hour despite continued ambulation. Peak plasma renin activity correlated well with the simultaneous fall in blood pressure (r = .91; P < .01), suggesting a compensatory response to the vascular effects of angiotensin blockade. On an ad lib. diet, saralasin infusion had no consistent effect on plasma renin activity serum potassium, or blood pressure, but in supine volunteers plasma aldosterone increased from 9.8 ± 2.1 to 16.5 ± 4.8 ng/dl, an average increase of 55 ± 17% (P < .05). Although mean plasma cortisol decreased, individual changes in cortisol did not correlate with changes in plasma aldosterone. These data suggest that saralasin has an agonist effect on basal aldosterone secretion.
Noth et al. (Fri,) conducted a other in Healthy volunteers (n=6). Saralasin vs. Baseline was evaluated on Systolic blood pressure (p=< .05). Saralasin infusion in healthy volunteers reduced systolic blood pressure from 106.2 to 95.8 mm Hg during sodium restriction (P<0.05) and increased basal aldosterone secretion.